11.01.2010: BIND announces the appointment of Scott Minick as President and CEO. Mr. Minick was formerly a Managing Director at ARCH Ventures and President and COO of SEQUIS Pharmaceuticals, where he led the company during its 1995 FDA approval and successful commercial launch of the leading oncology drug, Doxil (liposomal doxorubicin).

Press Release